2.4.0.8000320 - Disclosure - Note 5 - Accrued Liabilities (Details)truefalsefalse1false USDfalsefalse$Y09http://www.sec.gov/CIK0001455694duration2009-01-01T00:00:002009-12-31T00:00:00UsdPerShareDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$2false USDfalsefalse$E13Q2http://www.sec.gov/CIK0001455694instant2013-06-30T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$I090407http://www.sec.gov/CIK0001455694instant2009-04-07T00:00:000001-01-01T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_TextBlockAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Details2false 2fil_ProbableLiquidatedDamagesfil_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2truefalsefalse8573885738USD$falsetruefalse3falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false2Probable Liquidated Damages3false 2fil_LiquidDamages2PercentOfGrossProceedsfil_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse18000001800000USD$falsetruefalsexbrli:monetaryItemTypemonetaryNo authoritative reference available.No definition available.false2Liquid Damages 2 Percent of Gross Proceeds4false 2fil_HolderEntitledPricePerSharefil_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse47.3247.32USD$falsetruefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalNo authoritative reference available.No definition available.false3Holder Entitled Price Per Share5false 2fil_LiquidatedDamagesPaymentPerShareAmountfil_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1.001.00USD$falsetruefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalsenum:perShareItemTypedecimalNo authoritative reference available.No definition available.false3Liquidated Damages Payment Per Share AmountfalseNote 5 - Accrued Liabilities (Details) (USD $)NoRoundingUnKnownNoRoundingUnKnowntruefalsefalseSheethttp://signpathpharma.com/20130630/role/idr_DisclosureNote5AccruedLiabilitiesDetails35